Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia

Biomolecules. 2023 Mar 10;13(3):509. doi: 10.3390/biom13030509.

Abstract

Essential thrombocythemia (ET) is a blood cancer. ET is characterized by an overproduction of platelets that can lead to thrombosis formation. Platelet overproduction occurs in megakaryocytes through a signaling pathway that could involve JAK2, MPL, or CALR proteins. CALR mutations are associated with 25-30% of ET patients; CALR variants must be dimerized to induce ET. We classified these variants into five classes named A to E; classes A and B are the most frequent classes in patients with ET. The dynamic properties of these five classes using structural models of CALR's C-domain were analyzed using molecular dynamics simulations. Classes A, B, and C are associated with frameshifts in the C-domain. Their dimers can be stable only if a disulfide bond is formed; otherwise, the two monomers repulse each other. Classes D and E cannot be stable as dimers due to the absence of disulfide bonds. Class E and wild-type CALR have similar dynamic properties. These results suggest that the disulfide bond newly formed in classes A, B, and C may be essential for the pathogenicity of these variants. They also underline that class E cannot be directly related to ET but corresponds to human polymorphisms.

Keywords: CALR mutations; Protein Blocks; blood cancer; calcium; chronic myeloproliferative neoplasms; disulfide bonds; essential thrombocythemia; molecular dynamics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calreticulin* / genetics
  • Calreticulin* / metabolism
  • Disulfides / metabolism
  • Humans
  • Mutation
  • Thrombocythemia, Essential* / genetics
  • Thrombosis / genetics

Substances

  • Calreticulin
  • Disulfides
  • CALR protein, human

Grants and funding

This work was supported by grants from the Ministry of Research (France), Université Paris Cité (formerly University Paris Diderot, Sorbonne, Paris Cité, France and formerly Université de Paris), Université de la Réunion, the National Institute for Blood Transfusion (INTS, France), the National Institute for Health and Medical Research (INSERM, France), IdEx ANR-18-IDEX-0001, and labex GR-Ex. The labex GR-Ex, reference ANR-11-LABX-0051, is funded by the program “Investissements d’avenir” of the French National Research Agency, reference ANR-11-IDEX-0005-02.